WOMEN’S-ENTREPRENEURSHIP
13.9.2023 20:19:31 CEST | Business Wire | Press release
In alignment with the 78th session of the United Nations General Assembly, the Women’s Entrepreneurship Accelerator (WEA) is proud to announce a pivotal event spotlighting the pressing gap in financing for women-led businesses. This initiative is a collaborative effort with WEA-participating UN agencies, Mary Kay Global, Yildiz Holding, and the Women Entrepreneurs Act initiative (WE Act) of the Women20 (W20) countries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230913108266/en/
Titled “Inclusive Capital: Empowering Women Entrepreneurs on a Global Scale,” the WEA’s event at UNGA78 is a pivotal event spotlighting the pressing gap in financing for women-led businesses and aiming to foster dialogue among stakeholders in the women's entrepreneurship ecosystem. (Credit: Women’s Entrepreneurship Accelerator)
“Inclusive Capital: Empowering Women Entrepreneurs on a Global Scale”
Conference Room 2, United Nations Headquarters, NYC
Thursday 21 September 2023. Time: 6:00 pm – 8:00 pm ET
Register here
The event aims to foster dialogue among stakeholders in the women's entrepreneurship ecosystem. Discussions will revolve around the financial challenges women entrepreneurs face, the significance of inclusive investing, and the need for institutional and corporate entities to adopt a gender-inclusive perspective in their decision-making processes.
“Through the inception of the Women’s Entrepreneurship Accelerator, Mary Kay has helped carve a new path of intervention for the private sector,” said Deborah Gibbins, Chief Operating Officer, and Chief Financial Officer of Mary Kay Inc. “WEA is a groundbreaking partnership vehicle where the United Nations, public and private sectors, civil society organizations, and policy experts work together to transform the world WITH and FOR women entrepreneurs.”
The evening will commence with welcoming remarks from the executive leadership of UN Women followed by an introduction from Fulya Fraser, Chief Growth Officer at Pladis – part of the Yildiz Holding family of companies.
Two panel sessions will delve deep into the topics at hand:
- Accelerating Agenda 2030 through Women Entrepreneurship - Moderated by Virginia Littlejohn, Global Coordinator for Women Entrepreneurs Act (WE Act) designed to drive W20 action and implementation. The session will explore the "Trillion-dollar Opportunity in Supporting Women Entrepreneurs" and the potential economic impact if women-led businesses surmount financial barriers. Esteemed speakers include executive leaders from WEA UN partner agencies.
- Global Action for Women's Entrepreneurship - This session will spotlight major projects and programs in women entrepreneurship, featuring insights from international development leaders like Adriana Carvalho (W20Brazil), Wendy Teleki (World Bank), Marie-Christine Oghly (Femmes Chefs d’ Entreprise Mondiales - FCEM); Catherine Bosshart (Business and Professional Women - BPW), Anne Ravanona (Global InvestHER), Deborah Gibbins, Mary Kay Global, Lamia Kamal-Chaoui (Organisation for Economic Co-operation and Development - OECD).
The event's keynote will be delivered by Shazi Visram, Founder and CEO of Happy Family brands.
Registration is open until Sunday 17 September 2023 at 11:59 p.m. ET for in-person attendance at the UN Headquarters, NYC. For those unable to attend, the event will be streamed live on the United Nations Web TV website.
For more information and to register, click here.
About the Women’s Entrepreneurship Accelerator
The Women’s Entrepreneurship Accelerator (WEA) is a multi-stakeholder partnership on women’s entrepreneurship established during UNGA 74. It convenes six UN agencies, International Labour Organization (ILO), International Trade Centre (ITC), International Telecommunication Union (ITU), United Nations Development Programme (UNDP), United Nations Global Compact (UNGC), UN Women and Mary Kay Inc. to empower 5 million women entrepreneurs by 2030.
The ultimate goal of the initiative is to maximize the development impact of women entrepreneurship in achieving the Sustainable Development Goals (SDGs) by creating an enabling eco-system for women entrepreneurs around the world. The Accelerator exemplifies the transformational power of a multi-partnership of unique magnitude to harness the potential of women entrepreneurs.
Learn more at we-accelerate. Follow us: Twitter/X (We_Accelerator), Instagram (@we_accelerator), Facebook (@womensentrepreneurshipaccelerator), LinkedIn (@womensentrepreneurshipaccelerator)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230913108266/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom